See veebileht kasutab küpsiseid kasutaja sessiooni andmete hoidmiseks. Veebilehe kasutamisega nõustute ETISe kasutustingimustega. Loe rohkem
Olen nõus

Elvira Kurvinen

https://www.etis.ee/CV/Elvira_Kurvinen/est
4.08.1952
37255561980
+3726593969
elvira.kurvinen@tai.ee

Teenistuskäik

Töökohad ja ametid
2004–...   
Tervise Arengu Instituut, Vanemteadur (1,00)
01.01.2004–...   
Tervise Arengu Instituut, vanemteadur
01.01.1986–31.12.2004   
Eesti Kardioloogia Instituut, vanemteadur
01.01.1980–31.12.1986   
MTA Meditsiinilise Geneetika Instituudis Moskvas, kliiniline ordinaator, aspirant
01.01.1978–31.12.1980   
Kuressaare Haigla, arst
01.01.1977–31.12.1978   
Tallinna Keskhaigla, intern
 
 
Haridustee
1980–1986   
MTA Meditsiinilise Geneetika Instituut, kliiniline ordinatuur ja aspirantuur meditsiini geneetika alal
1971–1977   
Tartu Ülikooli Arstiteaduskond
 
 
Teadusorganisatsiooniline ja -administratiivne tegevus
2000−2002   
"Ateroskleroosi üldiste ja lipiidide ainevahetusega seotud riskitegurite dünaamika Tallinna noortes peredes "ETF grand 4061, grandijhoidja
1997−1999   
" Monogeensete lipiidmarkerite osa varajase SVH riskitegurina " ETF grand 2641, grandihoidja
1995−1997   
Sihtfinantseeritava teema "Spetsiifiliste SVH riskitegurite avastamine noortes peredes" juht
1994−1996   
"Mittenakkuslike haiguste riskitegurid noortes peredes ja meetmed nende profülaktikaks", ETF grand 134 , grandihoidja

Kvalifikatsioon

Teaduskraadid
Elvira Kurvinen, doktorikraad, 1987, (juh) Svetlana Kozlova; Mihhail Fuks, "Loote kaasasündinud väärarengute prognoosimine kliinilis-genealoogilise ja ultraheli uuringu alusel", Moskva, Venemaa.
 
 
Lisainfo
Meditsiiniteaduste kandidaat
MTA Meditsiinilise Geneetika Instituut, Moskva, Venemaa, 1987 a.
Terviseuuringud, Terviseuuringutega seotud uuringud (geneetika, biokeemia); ateroscleroosi uued riskitegurid; varajase ateroskleroosi prognoosimine; II tüüpi diabeedi kardiovaskulaarsed komplikatsioonid

Publikatsioonid

Klass
Aasta
Publikatsioon
 
5.2.
2010
Kurvinen, E.; Kahre, T.; Kirotar, K.; Žordania, R.; Tõnisson, N. (2010). Novel BRCA2 frameshift mutation detected in a woman woth multiple primary cancers. European Journal of Human Genetics, 1: European Human Genetics Conference; Göteborg, Rootsi; 12.-15. juuni, 2010. Nature Publishing Group, 166−166. (18).
5.1.
2009
Kurvinen, E.; Shois, M.; Joost, K.; Zordania, R. (2009). Recurrence of achondrogenesis type II within the same family. Nature publishing group: European Human Genetics Conference 2009. 89−89.
1.1.
2008
Aasvee, Katrin; Kurvinen, Elvira; Sundvall, Jouko; Jauhiainen, Matti; Tur, Inna. (2008). Aggregation of lipoprotein and inflammatory parameters in families with a premature myocardial infarction: the Tallinn Myocardial Infarction Study. Clinical Chemistry and Laboratory Medicine, 46 (11), 1602−1608.
1.3.
2008
Puusepp, Helen; Rein, Reet; Žordania, Riina; Kurvinen, Elvira; Jakovlev, Ülle; Õunap, Katrin. (2008). Fragiilse X-i sündroom Eestis: patsientide kliinilised ja sotsiaalsed probleemid. Eesti Arst, 87, 500−509.
1.3.
2008
Kurvinen, E.; Aasvee, K. (2008). Teist tüüpi suhkurtõve levimuse hindamise võimalus Eesti rahvastikus. Eesti Arst, 88, 87−91.
5.1.
2008
Kurvinen, E.; Nueganen, K.; Viigimaa, M.; Veske, A.; Aasvee, K. (2008). Matrix metalloproteinase-9 polymorphism in relation to cardiovascular disease complications in patients of type 2 diabetes mellitus. European Journal of Human Genetics, 16(Suppl 2): European Human Genetics Conference 2008, Barcelona, Spain, May 31 - June 3, 2008. , 326.
5.2.
2008
Aasvee, K.; Jauhiainen, M.; Viigimaa, M.; Tupits, H; Sundvall, J.; Kurvinen, E. (2008). Põletikumarkerid ja lipoproteiine remodelleerivad valgud II tüüpi diabeedi (T2DM) haigetel. Eesti Arst, 87(9): TÜ Arstiteaduskonna Päevad 2008, Tartu, 9-10 oktoober 2008. , 668−669.
5.2.
2008
Kurvinen, E; Viigimaa, M.; Tupits, H.; Sundvall, J.; Jauhiainen, M.; Aasvee, K. (2008). Lipiidide ainevahetuse näitajate ja süsteemse kroonilise põletiku markerite seos insuliiniresistentsuse väljendumuse astmega. Eesti Arst, 87(9): TÜ Arstiteaduskonna Päevad 2008, Tartu, 9-10 oktoober 2008. , 664−665.
5.2.
2007
Kurvinen, Elvira; Aasvee, Katrin (2007). Glucose metabolism, lipid profile and inflammatory markers in healthy subjects in relation to family history of type 2 diabetes mellitus. European Journal of Human Genetics., vol. 15: European Human Genetic Conference 2007, June 16-19, Nice, France. Nature Publishing Group, 329. (Supplements 1).
1.1.
2006
Aasvee, K.; Jauhiainen, M.; Kurvinen, E.; Tur, I.; Sundvall, J.; Roovere, T.; Baburin, A. (2006). Determinants of risk factors of atherosclerosis in the postinfarction period: The Tallinn MI Study. Scandinavian Journal of Clinical & Laboratory Investigation, 66 (3), 191−199. DOI: 10.1080/00365510600564881.
5.1.
2006
Kurvinen, E.; Aasvee, K.; Tupits, H. (2006). Lipid profile and glucose metabolism in patients of type 2 Diabetes mellitus in relation to family history. Europen Journal of Human Genetics: European Human Genetics Conference; Amsterdam, The Netherlands, May 6-9. 297.
1.1.
2005
Kurvinen, E.; Aasvee, K.; Zordania, R., Jauhiainen, M.; Sundvall, J. (2005). Serum lipid and apolipoprotein profiles in newborns and six-year-old children: The Tallinn Young Family Study. Scandinavian Journal of Clinical & Laboratory Investigation, 65 (7), 541−550. DOI: 10.1080/0365510500208324.
5.1.
2005
Zordania, R.; Zõrjanova, T.; Kurvinen, E.; Bartsch, O. (2005). Clinical and cytogenetic findings of 38 females with Turner syndrome in Estonia. European Journal of Human Genetics: European Human Genetics Conference 2005, Prague, Czech Republik, May 7-10. 109.
5.1.
2005
Aasvee, K.; Kurvinen, E.; Roovere, T.; Tupits, H.; Hedman, A.; Jauhiainen, M.; Sundvall, J. (2005). Cardiovascular risk factors in patients of type 2 diabetes mellitus with and without cardiovascular complications. Atherosclerosis: 75th European Atherosclerosis Society Congress, Prague, Czech Republic, April 23-26. 152. (6).
5.2.
2005
Kurvinen, E.; Zõrjanova, T.; Zordania, R.; Vool, I.; Jakovlev, Ü.; Kahre, T. (2005). Cytogenetic, moleculargenetic findings and syndromes in amenorrhoea etiology. European Journal of Human Genetics: European Human Genetics Conference 2005, Prague, Czech Republik, May 7-10. , 109.
1.1.
2004
Aasvee, K.; Kurvinen, E.; Jordania, R.; Jauhiainen, M.; Sundvall, J. (2004). Lipoprotein parameters in relation to other risk factors of atherosclerosis in adults and newborns: Tallinn Young Family Study. Scandinavian Journal of Clinical & Laboratory Investigation, 64 (3), 245−254. DOI: 10.1080/00365510410006009.
1.2.
2004
Tur, I.; Kurvinen, E.; Solodkaja, E.; Suurorg, L. (2004). Changes in cardiovascular disease risk factors in the offspring of parents with premature myocardial infarction during childhood and adolescence. Seminars in Cardiology, 10 (2), 91−94.
5.1.
2004
Kurvinen, E.; Aasvee, K.; Zhordania, R. (2004). Serum lipid and apolipoproteins in newborns and 6-year-old children in relation to apolipoprotein E phenotype. The Tallinn Young Family Study. Atherosclerosis Supplements, 5 (4), 5.
5.1.
2004
Aasvee, K.; Kurvinen, E.; Roovere, T.; Tupits, H.; Hedman, A.; Jauhiainen, M.; Sundvall, J. (2004). General characteristics of glucose and lipid metabolism in Tallinn Study of coronary risk factors in individuals with type 2 diabetes. Atherosclerosis Supplements, 5 (4), 1.
1.2.
2003
Kurvinen, E.; Aasvee, K.; Zordania, R. (2003). Cardiovascular Disease risk factors in preschool children. Papers on Anthropology, 113−123.
1.2.
2003
Aasvee, K.; Kurvinen, E.; Tur, I.; Jauhiainen, M.; Sundvall, J. (2003). Physical activity and biological risk factors of coronary heart disease: the study of premature myocardial infarction. Papers on Anthropology, XII, 11−20.
1.2.
2002
Kurvinen, E.; Aasvee, K.; Jordania, R. (2002). Association between birthweight and cardiovascular risk factors in adolescents. Papers on Anthropology, 125−134.
1.2.
2002
Aasvee, K.; Kurvinen, E.; Tur, I. (2002). Obesity as a risk factor for early myocardial infarction in men. Papers on Anthropology, 19−26.
1.2.
2001
Kurvinen, E.; Aasvee, K. (2001). Lipoprotein(a) - its physiology and role in cardiovascular diseases risk (review). The Baltic Atherosclerosis Journal, 2, 13−17.
1.3.
2001
Aasvee, K.; Kurvinen, E.; Zordania, R.; Sundvall, J.; Ehnholm, C.; Jauhiainen, M. (2001). Lipoproteiin (a) südame-veresoonkonnahaiguste riskitegurina noortes peredes. Eesti Arst, 80(7), 260−264.
5.1.
2001
Aasvee, K.; Kurvinen, E.; Tur, I. (2001). Lipoprotein profile and fibrinogen in survivors of early myocardial infarction and in their offspring. Japanese Journal of Cardiovascular Disease Prevention: The 4th International Hearth Health Conference, Osaka, Japan, May 27-31. 140.
5.2.
2001
Kurvinen, E.; Aasvee, K.; Jordania, R.; Jauhiainen, M.; Sundvall, J. (2001). The association between birth weight and CVD RF in adolescents. Japanese Journal of Cardiovascular Disease Prevention: The 4th International Hearth Health Conference, Osaka, Japan, May 27-31. 46.
1.3.
2000
Aasvee, K.; Lilienberg, K., Kurvinen, E.; Zordania, R., J auhiainen, M.; Ellamaa, M. (2000). Apolipoproteiinid A-I ja b keskealistel: normväärtused, ealine dünaamika. Eesti Arst, 79(12), 714−717.
1.1.
1999
Aasvee, K.; Jauhiainen, M.; Kurvinen, E.; Jordania, R.; Sundvall, J.; Ehnholm, C. (1999). Lipoprotein(a), apolipoprotein A-I and B serum levels in young families from Tallinn, Estonia. Relationships with other cardivascular risk factors and nationality. Scandinavian Journal of Clinical & Laboratory Investigation, 59, 179−190. DOI: 10.1080/00365519950185706.
1.1.
1999
Aasvee, K.; Jauhiainen, M.; Kurvinen, E.; Zordania, R.; Sundvall, J.; Ehnholm, C. (1999). Lipoprotein(a), Apolipoprotein A-I and B serum levels in young families from Tallinn, Estonia. Relationships with other cardiovascular risk factors and nationality. Scandinavian Journal of Clinical & Laboratory Investigation, 64 (3), 245−254. DOI: 10.1080/00365519950185706.
1.2.
1999
Aasvee, K.; Kurvinen, E. (1999). Apolipoprotein E polymorphism as a risk factor of coronary hear disease (review). The Baltic Atherosclerosis Journal, 1, 7−11.
1.2.
1999
Aasvee, K.; Jauhiainen, M.; Kurvinen, E.; Zordania, R.; Sundvall, J.; Ehnholm, C. (1999). Lipoprotein(a), Apolipoprotein a-I and B Serum Levels in Young Families From Tallinn, Estonia. Relationships With Other Cardiovascular Risk Factors and Nationality. Scandinavian Journal of Clinical & Laboratory Investigation, 3, 179−189.
1.2.
1999
Kurvinen, E.; Zordania, R.; Aasvee, K. (1999). Cardiovascular Risk Factors in Young Families. Relation to the Course of Pregnancy and the State of Health of the Newborn. Kardiologiya, 10, 52-56.
1.3.
1999
Aasvee, K.; Kurvinen, E.; Zordania, R. (1999). Toitumisharjumusi Tallinna noortes peredes ja nende mõju lipiidiainevahetuse näitajatele. Eesti Arst, 78 (3), 210−215.
1.3.
1997
Zordania, R.; Kurvinen, E.; Aasvee, K. (1997). Südame ja veresoonkonna haigused perekonnas ning aterogeensete lipiidide sisaldus vastsümdinueas. Eesti Arst, 57−58.
1.3.
1997
Kurvinen, E.; Zordania, R.; Aasvee, K. (1997). Sünnikaalu seos südame-ja veresoonkonna haiguste riskitegurite tekkega meestel. Eesti Arst, 25−26.
1.3.
1997
Aasvee, K.; Kurvinen, E.; Zordania, R. (1997). Apolipoproteiinid südamehaiguste prognoosimisel ja nende hinnangu kriteeriumid tallinnlastel. Eesti Arst, 4−5.
1.3.
1997
Kurvinen, E.; Jordania, R.; Aasvee, K. (1997). Cardiovascular diseases risk factors in women and pregnancy duration. Current Trends of the Prevention of Atherosclerosis in Childhood 2 (154−158).. Convention Budapest Ltd..
3.1.
1997
Jordania, R.; Kurvinen, E.; Aasvee, K. (1997). Pedigree data and atherogenic lipid fraction of newborns. Current Trends of the Prevention of Atherosclerosis in Childhood 2 (58−60).. Convention Budapest Ltd..
3.1.
1997
Aasvee, K.; Saava, M.; Jordania, R.; Kurvinen, E. (1997). Serum A-I and B in newborns and schoolchildren of Estonia with special reference to ethnic origin. Current Trends of the Prevention of Atherosclerosis in Childhood 2 (133−136).. Convention Budapest Ltd..
5.1.
1997
Jordania, R.; Kurvinen, E.; Aasvee, K. (1997). Clinical and lipid data of newborns and infants with CVD risk factors. The Canadian Journal of Cardiology: The 4th International Conference on Preventive Cardiology. 349.
5.1.
1997
Aasvee, K.; Kurvinen, E.; Jordania, R. (1997). Effect of dietary pattern on serum lipoprotein parameters in young families. Atherosclerosis, 134: 11th International Symposium on Atherosclerosis, Paris, 5-9 October. 152.
5.2.
1997
Kurvinen, E.;Jordania, R.; Aasvee, K. (1997). Young family as a unit for cardiovascular diseases prevention. The Canadian Journal of Cardiology: The 4th International Conference on Preventive Cardiology. 300.
1.3.
1994
Zordania, R.; Laan, M.; Kurvinen, E.; Tamm, L. (1994). Mittenakkuslike haiguste riskiteguritega laste kliinilis-genealoogiline iseloomustus. Eesti Arst, lisa, 55−58.
1.3.
1994
Luiga, E.; Tur, I.; Suurorg, L.; Kurvinen, E.; Rannula, U. (1994). Mittenakkuslike haiguste riskitegurite esinemissagedus Eesti erinevate piirkondade kooliõpilastel. Eesti Arst, 73 (4), 292−295.
1.3.
1994
Kurvinen, E.; Zordania, R. (1994). Mittenakkuslike haiguste riskitegurid rasedatel ja nende mõju vastsündinu tervisele. Eesti Arst, 73 (4), 280−281.
1.3.
1993
Tefanova, V.; Kremerman, I.; Priimägi, L.; Redko, L.; Kurvinen, E.; Mordvinova, H.; Pilar, M.. (1993). Eesti põlevkivibasseini laste tervise kliinilis-immunoloogiline iseloomustus. Eesti Arst, 3, 168−171.
1.3.
1992
Zordania, R.; Kurvinen, E. (1992). Meditsiini-geneetiline abi Tallinnas. Eesti Arst, 3, 210−214.
1.1.
1988
Kozlova, S.; Fuks, M.; Prytkov, A.; Kurvinen, E. (1988). Predicting the congenital defects of fetal development on the basis of clinical and genealogical examination of the parents. Akusherstvo i ginekologiia, 1, 37−40.
1.2.
1988
Kozlova, S.; Fuks, M.;Prytkov, A.;Kurvinen, E. (1988). Predicting the congenital defects of fetal development on the basis of clinical and genealogical examination of the parents. Akusherstvo Ginekologia, 1, 37−40.
30.10.2019

Elvira Kurvinen

https://www.etis.ee/CV/Elvira_Kurvinen/eng

Publications

Category
Year
Publication
 
5.2.
2007
Kurvinen, Elvira; Aasvee, Katrin (2007). Glucose metabolism, lipid profile and inflammatory markers in healthy subjects in relation to family history of type 2 diabetes mellitus. European Journal of Human Genetics., vol. 15: European Human Genetic Conference 2007, June 16-19, Nice, France. Nature Publishing Group, 329. (Supplements 1).
1.1.
2006
Aasvee, K.; Jauhiainen, M.; Kurvinen, E.; Tur, I.; Sundvall, J.; Roovere, T.; Baburin, A. (2006). Determinants of risk factors of atherosclerosis in the postinfarction period: The Tallinn MI Study. Scandinavian Journal of Clinical & Laboratory Investigation, 66 (3), 191−199. DOI: 10.1080/00365510600564881.
5.1.
2006
Kurvinen, E.; Aasvee, K.; Tupits, H. (2006). Lipid profile and glucose metabolism in patients of type 2 Diabetes mellitus in relation to family history. Europen Journal of Human Genetics: European Human Genetics Conference; Amsterdam, The Netherlands, May 6-9. 297.
1.1.
2005
Kurvinen, E.; Aasvee, K.; Zordania, R., Jauhiainen, M.; Sundvall, J. (2005). Serum lipid and apolipoprotein profiles in newborns and six-year-old children: The Tallinn Young Family Study. Scandinavian Journal of Clinical & Laboratory Investigation, 65 (7), 541−550. DOI: 10.1080/0365510500208324.
5.1.
2005
Zordania, R.; Zõrjanova, T.; Kurvinen, E.; Bartsch, O. (2005). Clinical and cytogenetic findings of 38 females with Turner syndrome in Estonia. European Journal of Human Genetics: European Human Genetics Conference 2005, Prague, Czech Republik, May 7-10. 109.
5.1.
2005
Aasvee, K.; Kurvinen, E.; Roovere, T.; Tupits, H.; Hedman, A.; Jauhiainen, M.; Sundvall, J. (2005). Cardiovascular risk factors in patients of type 2 diabetes mellitus with and without cardiovascular complications. Atherosclerosis: 75th European Atherosclerosis Society Congress, Prague, Czech Republic, April 23-26. 152. (6).
5.2.
2005
Kurvinen, E.; Zõrjanova, T.; Zordania, R.; Vool, I.; Jakovlev, Ü.; Kahre, T. (2005). Cytogenetic, moleculargenetic findings and syndromes in amenorrhoea etiology. European Journal of Human Genetics: European Human Genetics Conference 2005, Prague, Czech Republik, May 7-10. , 109.
1.1.
2004
Aasvee, K.; Kurvinen, E.; Jordania, R.; Jauhiainen, M.; Sundvall, J. (2004). Lipoprotein parameters in relation to other risk factors of atherosclerosis in adults and newborns: Tallinn Young Family Study. Scandinavian Journal of Clinical & Laboratory Investigation, 64 (3), 245−254. DOI: 10.1080/00365510410006009.
1.2.
2004
Tur, I.; Kurvinen, E.; Solodkaja, E.; Suurorg, L. (2004). Changes in cardiovascular disease risk factors in the offspring of parents with premature myocardial infarction during childhood and adolescence. Seminars in Cardiology, 10 (2), 91−94.
5.1.
2004
Kurvinen, E.; Aasvee, K.; Zhordania, R. (2004). Serum lipid and apolipoproteins in newborns and 6-year-old children in relation to apolipoprotein E phenotype. The Tallinn Young Family Study. Atherosclerosis Supplements, 5 (4), 5.
5.1.
2004
Aasvee, K.; Kurvinen, E.; Roovere, T.; Tupits, H.; Hedman, A.; Jauhiainen, M.; Sundvall, J. (2004). General characteristics of glucose and lipid metabolism in Tallinn Study of coronary risk factors in individuals with type 2 diabetes. Atherosclerosis Supplements, 5 (4), 1.
1.2.
2003
Kurvinen, E.; Aasvee, K.; Zordania, R. (2003). Cardiovascular Disease risk factors in preschool children. Papers on Anthropology, 113−123.
1.2.
2003
Aasvee, K.; Kurvinen, E.; Tur, I.; Jauhiainen, M.; Sundvall, J. (2003). Physical activity and biological risk factors of coronary heart disease: the study of premature myocardial infarction. Papers on Anthropology, XII, 11−20.
1.2.
2002
Kurvinen, E.; Aasvee, K.; Jordania, R. (2002). Association between birthweight and cardiovascular risk factors in adolescents. Papers on Anthropology, 125−134.
1.2.
2002
Aasvee, K.; Kurvinen, E.; Tur, I. (2002). Obesity as a risk factor for early myocardial infarction in men. Papers on Anthropology, 19−26.
1.2.
2001
Kurvinen, E.; Aasvee, K. (2001). Lipoprotein(a) - its physiology and role in cardiovascular diseases risk (review). The Baltic Atherosclerosis Journal, 2, 13−17.
1.3.
2001
Aasvee, K.; Kurvinen, E.; Zordania, R.; Sundvall, J.; Ehnholm, C.; Jauhiainen, M. (2001). Lipoproteiin (a) südame-veresoonkonnahaiguste riskitegurina noortes peredes. Eesti Arst, 80(7), 260−264.
5.1.
2001
Aasvee, K.; Kurvinen, E.; Tur, I. (2001). Lipoprotein profile and fibrinogen in survivors of early myocardial infarction and in their offspring. Japanese Journal of Cardiovascular Disease Prevention: The 4th International Hearth Health Conference, Osaka, Japan, May 27-31. 140.
5.2.
2001
Kurvinen, E.; Aasvee, K.; Jordania, R.; Jauhiainen, M.; Sundvall, J. (2001). The association between birth weight and CVD RF in adolescents. Japanese Journal of Cardiovascular Disease Prevention: The 4th International Hearth Health Conference, Osaka, Japan, May 27-31. 46.
1.3.
2000
Aasvee, K.; Lilienberg, K., Kurvinen, E.; Zordania, R., J auhiainen, M.; Ellamaa, M. (2000). Apolipoproteiinid A-I ja b keskealistel: normväärtused, ealine dünaamika. Eesti Arst, 79(12), 714−717.
1.1.
1999
Aasvee, K.; Jauhiainen, M.; Kurvinen, E.; Jordania, R.; Sundvall, J.; Ehnholm, C. (1999). Lipoprotein(a), apolipoprotein A-I and B serum levels in young families from Tallinn, Estonia. Relationships with other cardivascular risk factors and nationality. Scandinavian Journal of Clinical & Laboratory Investigation, 59, 179−190. DOI: 10.1080/00365519950185706.
1.2.
1999
Aasvee, K.; Kurvinen, E. (1999). Apolipoprotein E polymorphism as a risk factor of coronary hear disease (review). The Baltic Atherosclerosis Journal, 1, 7−11.
1.2.
1999
Kurvinen, E.; Zordania, R.; Aasvee, K. (1999). Cardiovascular Risk Factors in Young Families. Relation to the Course of Pregnancy and the State of Health of the Newborn. Kardiologiya, 10, 52-56.
5.1.
1997
Jordania, R.; Kurvinen, E.; Aasvee, K. (1997). Clinical and lipid data of newborns and infants with CVD risk factors. The Canadian Journal of Cardiology: The 4th International Conference on Preventive Cardiology. 349.
5.1.
1997
Aasvee, K.; Kurvinen, E.; Jordania, R. (1997). Effect of dietary pattern on serum lipoprotein parameters in young families. Atherosclerosis, 134: 11th International Symposium on Atherosclerosis, Paris, 5-9 October. 152.
5.2.
1997
Kurvinen, E.;Jordania, R.; Aasvee, K. (1997). Young family as a unit for cardiovascular diseases prevention. The Canadian Journal of Cardiology: The 4th International Conference on Preventive Cardiology. 300.
1.1.
1988
Kozlova, S.; Fuks, M.; Prytkov, A.; Kurvinen, E. (1988). Predicting the congenital defects of fetal development on the basis of clinical and genealogical examination of the parents. Akusherstvo i ginekologiia, 1, 37−40.
1.2.
1988
Kozlova, S.; Fuks, M.;Prytkov, A.;Kurvinen, E. (1988). Predicting the congenital defects of fetal development on the basis of clinical and genealogical examination of the parents. Akusherstvo Ginekologia, 1, 37−40.
30.10.2019

Otsi projekti

  • {{item.Name}}
Asutus on projekti finantseerija   Asutus on projekti teostaja  
  • {{searchListItem.Name}}
Kõik   Tavaprojektid   Ülemprojektid   Alamprojektid  
Uus Frascati (2015)
Uus ja vana Frascati (otsing uue järgi väljastab ka seotud vanad)
Kõik
Käimasolevad
Lõppenud
Algus
Hajus
Täpne
Lihtotsing Tühjenda
  • Leitud 4 kirjet
ProgrammLiikNumberNimiProjekti algusProjekti lõppVastutav täitjaAsutusFinantseerijapoolne rahastamine
SFSF0182548Bs03II tüüpi diabeediga seotud ateroskleroosi riskitegurite kompleks südamelihase infarkti etioloogias (M. Zilmeri teema "Endoteeli düsfunktsionaalsuse ja neurodegeneratsiooni oksüdatiivse stressi põhine mudel" alateema)01.01.200331.12.2005Katrin AasveeTervise Arengu Instituut54 260,99 EUR
ETFETF5956Seosed kroonilise põletiku markerite ja lipoproteiinide parameetrite vahel II tüübi diabeedi haigetel01.01.200431.12.2007Katrin AasveeTervise Arengu Instituut25 134,57 EUR
SFSF0942706s06Sotsiaalmajanduslikust ning psühhosotsiaalsest keskkonnast ja mittetervislikust käitumisest tingitud tervisehäirete kujunemise põhjuslikud mehhanismid01.01.200631.12.2011Toomas VeidebaumTervise Arengu Instituut645 493,32 EUR
1.2.3.2.YO21 (016181)Toitumisharjumustest ja elustiilist tingitud tervisemõjude hindamine ning ennetamine lastel (IDEFICS)01.09.200631.08.2011Toomas VeidebaumTervise Arengu Instituut386 000,03 EUR